|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-1-23
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Pharmacogenetic determinants of the response of patients to clopidogrel contribute to variability in the biologic antiplatelet activity of the drug. The effect of these determinants on clinical outcomes after an acute myocardial infarction is unknown.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ABCB1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Aryl Hydrocarbon Hydroxylases,
http://linkedlifedata.com/resource/pubmed/chemical/CYP2C19 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/CYP3A5 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 CYP3A,
http://linkedlifedata.com/resource/pubmed/chemical/ITGB3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Integrin beta3,
http://linkedlifedata.com/resource/pubmed/chemical/P-Glycoprotein,
http://linkedlifedata.com/resource/pubmed/chemical/P2RY12 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Purinergic P2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Purinergic P2Y12,
http://linkedlifedata.com/resource/pubmed/chemical/Ticlopidine,
http://linkedlifedata.com/resource/pubmed/chemical/clopidogrel
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:BecquemontLaurentL,
pubmed-author:DanchinNicolasN,
pubmed-author:DrouetElodieE,
pubmed-author:FerrièresJeanJ,
pubmed-author:French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial...,
pubmed-author:MéneveauNicolasN,
pubmed-author:Mary-KrauseMurielleM,
pubmed-author:QuteinehLinaL,
pubmed-author:SimonTabassomeT,
pubmed-author:StegP GabrielPG,
pubmed-author:VerstuyftCélineC
|
|
pubmed:copyrightInfo |
2009 Massachusetts Medical Society
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
22
|
|
pubmed:volume |
360
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
363-75
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19106083-Aged,
pubmed-meshheading:19106083-Angioplasty, Balloon, Coronary,
pubmed-meshheading:19106083-Aryl Hydrocarbon Hydroxylases,
pubmed-meshheading:19106083-Combined Modality Therapy,
pubmed-meshheading:19106083-Cytochrome P-450 CYP3A,
pubmed-meshheading:19106083-Female,
pubmed-meshheading:19106083-Follow-Up Studies,
pubmed-meshheading:19106083-Genotype,
pubmed-meshheading:19106083-Humans,
pubmed-meshheading:19106083-Integrin beta3,
pubmed-meshheading:19106083-Male,
pubmed-meshheading:19106083-Middle Aged,
pubmed-meshheading:19106083-Mortality,
pubmed-meshheading:19106083-Mutation,
pubmed-meshheading:19106083-Myocardial Infarction,
pubmed-meshheading:19106083-P-Glycoprotein,
pubmed-meshheading:19106083-Platelet Aggregation,
pubmed-meshheading:19106083-Platelet Aggregation Inhibitors,
pubmed-meshheading:19106083-Polymorphism, Genetic,
pubmed-meshheading:19106083-Receptors, Purinergic P2,
pubmed-meshheading:19106083-Receptors, Purinergic P2Y12,
pubmed-meshheading:19106083-Registries,
pubmed-meshheading:19106083-Stroke,
pubmed-meshheading:19106083-Ticlopidine
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Genetic determinants of response to clopidogrel and cardiovascular events.
|
|
pubmed:affiliation |
Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, and Université Pierre et Marie Curie, Paris 06, France. tabassome.simon@sat.aphp.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
